VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) financials

VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Market Cap: ₹14,231Cr.
Current Price: ₹1,382
Stock P/E: 73.8
ROE: 19.5%
ROCE: 21.5%
Book Value: ₹91.7
Dividend Yield: 0.14%
52W High / Low: ₹1,594/848

In Jun 2026, VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) reported sales ₹219 Cr and net profit ₹53 Cr.

Annual TTM: sales ₹808 Cr, net profit ₹193 Cr.

Shareholding: Promoters 52.46% (Sep 2026), FIIs 10.67% (Sep 2026), DIIs 32.49% (Sep 2026), Public 4.38% (Sep 2026), No. of Shareholders 70,966% (Sep 2026).

VIJAYA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	170	156	162	177	189	193	207	219
Expenses	100	94	97	107	111	110	115	124
Operating Profit	71	62	65	71	79	83	92	95
OPM %	41%	40%	40%	40%	41%	43%	44%	43%
Other Income	5	5	4	7	5	6	7	9
Interest	6	6	7	7	7	8	9	10
Depreciation	15	17	17	18	19	21	21	22
Profit before tax	54	44	46	53	57	59	69	71
Tax %	26%	24%	27%	26%	25%	25%	23%	25%
Net Profit	40	34	33	39	43	44	53	53
EPS in Rs	3.87	3.27	3.26	3.80	4.16	4.30	5.14	5.17
Raw PDF	—	—	—	—	—	—	—	—

VIJAYA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	329	367	451	450	525	634	765	808
Expenses	196	204	251	271	313	379	443	460
Operating Profit	133	163	200	179	212	255	322	347
OPM %	40%	44%	44%	40%	40%	40%	42%	43%
Other Income	12	11	13	15	19	17	25	27
Interest	15	15	16	21	24	25	31	34
Depreciation	48	50	52	61	55	65	80	84
Profit before tax	82	110	144	111	152	183	236	256
Tax %	25%	24%	25%	25%	25%	26%	25%	—
Net Profit	61	83	108	83	115	136	178	193
EPS in Rs	6.01	8.12	10.60	8.15	11.20	13.24	17.33	18.77
Dividend Payout %	0%	0%	9%	12%	9%	15%	12%	—

VIJAYA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	5	5	10	10	10	10	10
Reserves	211	273	356	460	535	643	770	933
Borrowings	36	156	137	183	248	250	292	396
Other Liabilities	40	41	36	58	57	59	149	120
Total Liabilities	292	475	533	711	850	962	1,221	1,460
Fixed Assets	137	264	261	364	517	582	673	862
CWIP	3	10	9	34	28	9	67	35
Investments	73	58	32	59	144	254	326	368
Other Assets	80	143	231	254	161	117	154	195
Total Assets	292	475	533	711	850	962	1,221	1,460

VIJAYA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	77	109	128	155	163	175	208	256
Cash from Investing Activity	-91	-34	-129	-127	-108	-139	-167	-166
Cash from Financing Activity	8	-28	-48	-25	-41	-43	-47	-63
Net Cash Flow	-7	46	-49	4	13	-8	-5	27
Free Cash Flow	18	62	97	35	38	92	137	91
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	104%	99%	97%	97%	105%	98%	96%	95%

VIJAYA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	53.91%	53.05%	52.63%	52.60%	52.60%	52.51%	52.51%	52.46%
FIIs	17.54%	19.36%	19.56%	18.27%	15.10%	13.38%	11.65%	10.67%
DIIs	24.62%	23.72%	24.07%	25.34%	28.60%	29.93%	31.61%	32.49%
Public	3.92%	3.86%	3.73%	3.77%	3.70%	4.17%	4.22%	4.38%
No. of Shareholders	60,952	66,891	62,115	58,994	57,784	62,946	67,251	70,966

VIJAYA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	14	9	7	8	7	9	7	10
Inventory Days	19	23	16	22	12	26	18	18
Days Payable	175	163	133	108	172	178	141	143
Cash Conversion Cycle	-142	-130	-110	-79	-153	-143	-116	-114
Working Capital Days	-28	-40	-21	-32	-37	-28	-47	-35
ROCE %	33%	27%	27%	28%	18%	19%	20%	22%

VIJAYAUpdated 19 Oct 2026, 8:00

Vijaya Diagnostic Cen Ltd

VIJAYAUpdated 19 Oct 2026, 8:00

Market Cap

₹14,231Cr.

Current Price

₹1,382

High / Low

₹1,594/848

Stock P/E

73.8

ROE19.5%

ROCE21.5%

Book Value₹91.7

Face Value₹1.00

Dividend Yield0.14%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	119	6	71	6	12	35	26	26	2.55
Sep 2023	136	6	80	7	14	44	25	33	3.21
Dec 2023	129	6	78	3	14	34	25	25	2.47
Mar 2024	141	6	84	3	15	40	23	31	2.98
Jun 2024	142	6	87	4	15	38	25	29	2.81
Sep 2024	170	6	100	5	15	54	26	40	3.87
Dec 2024	156	6	94	5	17	44	24	34	3.27
Mar 2025	162	7	97	4	17	46	27	33	3.26
Jun 2025	177	7	107	7	18	53	26	39	3.8
Sep 2025	189	7	111	5	19	57	25	43	4.16
Dec 2025	193	8	110	6	21	59	25	44	4.3
Mar 2026	207	9	115	7	21	69	23	53	5.14
Jun 2026	219	10	124	9	22	71	25	53	5.17

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2018	238	4	160	5	23	56	36	35	3.47
Mar 2019	279	4	187	9	26	70	31	49	4.8
Mar 2020	329	15	196	12	48	82	25	61	6.01
Mar 2021	367	15	204	11	50	110	24	83	8.12
Mar 2022	451	16	251	13	52	144	25	108	10.6
Mar 2023	450	21	271	15	61	111	25	83	8.15
Mar 2024	525	24	313	19	55	152	25	115	11.2
Mar 2025	634	25	379	17	65	183	26	136	13.24
Mar 2026	765	31	443	25	80	236	25	178	17.33
TTM	808	34	460	27	84	256	—	193	18.77

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	52.46%
FIIs	10.67%
DIIs	32.49%
Public	4.38%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	54.87%	19.95%	19.82%	5.36%
Mar 2024	54.06%	20.09%	20.8%	5.03%
Jun 2024	53.92%	20.08%	21.49%	4.5%
Sep 2024	53.91%	18.14%	23.45%	4.49%
Dec 2024	53.91%	17.54%	24.62%	3.92%
Mar 2025	53.05%	19.36%	23.72%	3.86%
Jun 2025	52.63%	19.56%	24.07%	3.73%
Sep 2025	52.6%	18.27%	25.34%	3.77%
Dec 2025	52.6%	15.1%	28.6%	3.7%
Mar 2026	52.51%	13.38%	29.93%	4.17%
Jun 2026	52.51%	11.65%	31.61%	4.22%
Sep 2026	52.46%	10.67%	32.49%	4.38%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2018	5	162	26	31	224	102	3	77	42	224
Mar 2019	5	211	36	40	292	137	3	73	80	292
Mar 2020	5	273	156	41	475	264	10	58	143	475
Mar 2021	5	356	137	36	533	261	9	32	231	533
Mar 2022	10	460	183	58	711	364	34	59	254	711
Mar 2023	10	535	248	57	850	517	28	144	161	850
Mar 2024	10	643	250	59	962	582	9	254	117	962
Mar 2025	10	770	292	149	1221	673	67	326	154	1221
Mar 2026	10	933	396	120	1460	862	35	368	195	1460

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2018	62	-100	-7	-44
Mar 2019	77	-91	8	-7
Mar 2020	109	-34	-28	46
Mar 2021	128	-129	-48	-49
Mar 2022	155	-127	-25	4
Mar 2023	163	-108	-41	13
Mar 2024	175	-139	-43	-8
Mar 2025	208	-167	-47	-5
Mar 2026	256	-166	-63	27

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	14	14	9	7	8	7	9	7	10
Inventory Days	24	19	23	16	22	12	26	18	18
Days Payable	152	175	163	133	108	172	178	141	143
Cash Conversion Cycle	-115	-142	-130	-110	-79	-153	-143	-116	-114
Working Capital Days	-22	-28	-40	-21	-32	-37	-28	-47	-35
ROCE %	—	33%	27%	27%	28%	18%	19%	20%	22%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of VIJAYA DIAGNOSTIC CEN LTD (VIJAYA)?

The reported market capitalisation for VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) is ₹14,231Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of VIJAYA?

The current price shown for VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) on Fincrux is ₹1,382 with a 52-week high/low of ₹1,594/848.

What is the P/E ratio of VIJAYA DIAGNOSTIC CEN LTD (VIJAYA)?

The stock P/E for VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) is 73.8 on Fincrux, with ROE at 19.5% and ROCE at 21.5%.

What were VIJAYA latest quarterly results?

For Jun 2026, VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) reported sales ₹219 Cr and net profit ₹53 Cr (figures in ₹ crore unless noted).

What are VIJAYA annual sales and net profit?

For TTM, VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) shows sales of ₹808 Cr and net profit of ₹193 Cr on the Fincrux profit & loss statement.

Who owns VIJAYA DIAGNOSTIC CEN LTD (VIJAYA)?

Latest shareholding for VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) on Fincrux: Promoters 52.46% (Sep 2026), FIIs 10.67% (Sep 2026), DIIs 32.49% (Sep 2026), Public 4.38% (Sep 2026), No. of Shareholders 70,966% (Sep 2026).

Where can I find VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) financials?

VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show VIJAYA balance sheet and cash flow?

Yes. The VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 8:00